 13. Start or change of dose of tricyclic or tetracyclic antidepressants, cardio glycosides, beta blockers or calcium channel blockers or other anti-hypertensive agents 3 months 90 days prior to baseline or throughout the study. Use of such therapy must remain constant during the study. 